Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02475031 · ClinicalTrials.gov registry record · Phase 4

Single-shot TAP Block vs Continuous TAP Block

A Phase 4 study of Postoperative Pain, sponsored by Indiana University.

Completed
Registry status
Phase 4
Development phase
70
Enrollment target
1
Study location

NCT02475031: Completed Phase 4 study of Postoperative Pain, sponsored by Indiana University.

NCT02475031 is a Phase 4 study of Postoperative Pain that has completed, run by Indiana University. The registered enrollment target is 70 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02475031, a Phase 4 study of Postoperative Pain, has completed, sponsored by Indiana University.

COMPLETED
Registry status
Phase 4
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether continuous transversus abdominis plane (TAP) block is superior to single shot TAP for postoperative pain after laparoscopic donor nephrectomy

Primary Outcome

The primary endpoint of this study will be narcotic requirement at 48 hours

Conditions Studied

Interventions

  • DEVICE TAP-C
  • DRUG TAP-S

Study Locations (1)

Indiana

  • Indiana University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2012-07
Est. Completion 2015-12
Phase Phase 4
Indiana University

890 total trials

What the finished NCT02475031 record still lists

NCT02475031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (70% lower).

The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 2 interventions - of which TAP-C is the first listed.

NCT02475031 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT02475031 about?

NCT02475031 is a clinical study titled "Single-shot TAP Block vs Continuous TAP Block". The purpose of this study is to determine whether continuous transversus abdominis plane (TAP) block is superior to single shot TAP for postoperative pain after laparoscopic donor nephrectomy

What is the current status of trial NCT02475031?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2012-07. Estimated completion is 2015-12.

What conditions does trial NCT02475031 study?

This clinical trial studies the following conditions: Postoperative Pain.

What interventions are being tested in trial NCT02475031?

The interventions under investigation include: TAP-C (DEVICE), TAP-S (DRUG).

Who is sponsoring clinical trial NCT02475031?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02475031 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Postoperative Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02475031's enrollment target sits among peer trials

70 86th of 120 higher than 33 of 120 other Postoperative Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02475031, the US trial registry maintained by the National Library of Medicine. NCT02475031 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.